Home › NDC Lookup › RxCUI directory › RxCUI 1547225

Eliglustat 84 MG Oral Capsule — RxCUI 1547225

RxNorm drug concept · Semantic clinical drug
RxCUI 1547225 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1547225
Official nameEliglustat 84 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aseliglustat 84 MG (as eliglustat tartrate 100 MG) Oral Capsule
FDA products mapped1
Package NDCs mapped2
Reported Medicaid activity (SDUD)453 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Eliglustat: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Cerdelga is used to treat Gaucher disease type 1, which is a condition where a fatty substance builds up in your liver, spleen, and bone marrow because your body lacks a key enzyme...
  • What exactly is Cerdelga used for, and how is it different from other Gaucher treatments?
  • Cerdelga is processed in your body by a liver enzyme called CYP2D6, and people naturally vary in how active that enzyme is. Your genetic type — called your metabolizer status — det...
  • Why did I need a genetic test before starting this medication?
📖 Read our full Eliglustat guide →

🕸️ Concept Web — How Eliglustat 84 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Eliglustat 84 MG Oral Capsule RxCUI 1547225

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Eliglustat 1547220
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cerdelga 1547226
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Eliglustat Oral Capsule 1547224
    • Eliglustat Oral Product 1547222
    • Eliglustat Pill 1547223
    • Eliglustat Oral Capsule [Cerdelga] 1547228
    • Cerdelga Oral Product 1547229
    • Cerdelga Pill 1547230
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Eliglustat 84 MG SCDC · 1547221
  • Eliglustat Oral Capsule SCDF · 1547224
  • Eliglustat Oral Product SCDG · 1547222
  • Eliglustat Pill SCDG · 1547223

Brand-Name Concepts

  • Eliglustat 84 MG Oral Capsule [Cerdelga] SBD · 1547231
  • Eliglustat 84 MG [Cerdelga] SBDC · 1547227
  • Eliglustat Oral Capsule [Cerdelga] SBDF · 1547228
  • Cerdelga Oral Product SBDG · 1547229
  • Cerdelga Pill SBDG · 1547230
  • Cerdelga BN · 1547226

📦 FDA Products & Package NDCs

1 product · 2 package NDCs
2 package NDCs map to RxCUI 1547225 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
58468-0220-01 4 BLISTER PACK in 1 CARTON (58468-0220-1) / 14 CAPSULE in 1... Cerdelga Genzyme Corporation 2014-09-03
58468-0220-02 1 BLISTER PACK in 1 CARTON (58468-0220-2) / 14 CAPSULE in 1... Cerdelga Genzyme Corporation 2014-09-03
Observed labelers: Genzyme Corporation (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.